Search results
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Grey Wolf gains $50m boost for antigen modulation tech
Pharmaceutical Technology via Yahoo Finance· 7 hours agoICG's Life Sciences team spearheaded the Series B expansion, with support from current investors...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WHTC 1450 Holland· 2 days ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
The Flash May PMI Report Claps Back on Rate Cut Expectations
TheStreet.com· 1 day agoThe data shows an upturn in the economy with inflation pressures not backing down. * The Flash May...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks· 2 days agoFree Report) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 200-day moving average, and this suggests a long-term bullish trend. The ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 1 day agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 1 day agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 7 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 2 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
Pfizer recalls 5 drug lots for potential packaging error
Becker’s Hospital Review· 2 days agoThree lots of buprenorphine hydrochloride, used for pain management, and two lots of labetalol hydrochloride, indicated for blood pressure control in severe hypertension cases, were recalled ...
